ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Takuya Miura
John E. Mayer, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, D. P.
Right arrow Articles by Neufeld, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, D. P.
Right arrow Articles by Neufeld, E. J.
Related Collections
Right arrow Extracorporeal circulation

Ann Thorac Surg 2002;73:156-162
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion

David P. Nelson, MD*a, Stephanie Burns Wechsler, MDa, Takuya Miura, MDb, Amy Staggc, Jane W. Newburger, MDa, John E. Mayer, Jr, MDb, Ellis J. Neufeld, MDc

a Department of Cardiology, Children’s Hospital, Harvard Medical School, Boston, MA, USA
b Department of Cardiac Surgery, Children’s Hospital, Harvard Medical School, Boston, MA, USA
c Division of Hematology, Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Accepted for publication August 2, 2001.

* Address reprint requests to Dr Nelson, Division of Pediatric Cardiology, Children’s Hospital Medical Center, OSB-4, 3333 Burnet Ave, Cincinnati, OH 45229, USA
e-mail: davenelson{at}chmcc.org


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Background. The inflammatory process after cardiopulmonary bypass is accompanied by alterations in gene expression for various inflammatory mediators.

Methods. To analyze differential gene expression after myocardial ischemia-reperfusion, subtraction hybridization was used to discover induction of TIS7/PC4, an immediate early gene heretofore not observed in the heart. This prompted characterization of the related immediate early genes c-fos and c-jun, by Northern analysis and in situ hybridization in human and lamb myocardium subjected to cardiopulmonary bypass with myocardial ischemia. For comparison, we analyzed expression of inducible nitric oxide synthase (iNOS), which requires cytokine-activation, resulting in a "delayed" response.

Results. In ischemic-reperfused myocardium at end-cardiopulmonary bypass, c-fos, c-jun, and TIS7/PC4 were induced, whereas iNOS transcripts were undetectable. Expression patterns of c-fos and c-jun by in situ hybridization were markedly different; myocardial c-fos expression was diffuse and homogeneous, whereas c-jun expression was patchy with areas of intense focal localization.

Conclusions. Cardiopulmonary bypass with myocardial ischemia rapidly induces the immediate early genes TIS7/PC4 (discovered by subtraction hybridization), and c-fos and c-jun (precursors to the transcriptional regulator AP-1). Immediate early genes presumably contribute to activation of inflammatory mediators after cardiopulmonary bypass and differences in their tissue expression patterns, as observed for c-fos and c-jun, presumably modulate their effect upon downstream gene activation.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA) circulatory support techniques used for cardiac operations, are known to contribute to postoperative inflammatory tissue injury and organ system dysfunction [1, 2]. Initiators of inflammation include activation of blood components by the bypass apparatus and ischemia-reperfusion injury, resulting from the obligate period of ischemia (and pursuant reperfusion) that occurs with cardiopulmonary bypass. Inflammatory tissue injury after cardiac operation contributes to morbidity and mortality because the organs most significantly affected include the heart, lungs, and central nervous system [3].

Investigations from our group and others have demonstrated that the inflammatory process after CPB is accompanied by alterations in gene expression for various inflammatory mediators and adhesion molecules [46]. Because the molecular pathways linking CPB and ischemia-reperfusion to changes in gene expression remain obscure, we used subtraction hybridization to identify other induced genes in neonatal lamb hearts subjected to CPB with associated myocardial ischemia-reperfusion. One of the clones isolated by subtraction hybridization was the early response gene TIS7/PC4 [79], an immediate early gene cloned in neurally-derived tissue but not previously observed in the heart. The subtraction hybridization results prompted us to characterize expression of the related immediate early gene precursors of the transcription factor AP-1, c-fos and c-jun [10], in human and ovine myocardium subjected to CPB and associated ischemia-reperfusion. For comparison, we assessed myocardial mRNA expression of inducible nitric oxide synthase (iNOS), a "delayed response gene" requiring cytokine-activation [11].


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Neonatal lamb CPB/DHCA model
Myocardial tissues for subtraction-hybridization, Northern analysis and in-situ hybridization were harvested from neonatal lambs subjected to CPB/DHCA immediately upon termination of bypass (n = 3) or control animals undergoing sternotomy with 3 hours anesthesia and no myocardial ischemia (n = 3). Tissue samples were immediately frozen in liquid nitrogen upon harvest.

The neonatal lamb CPB/DHCA model has been previously characterized and described [12]. Briefly, neonatal lambs were anesthetized, paralyzed, and ventilated. The heart was exposed by sternotomy and catheters placed for hemodynamic monitoring. After systemic heparinization, a 5-French sheath was inserted into the apex of the left ventricle for venting during bypass. The CPB circuit was primed with homologous donor blood to achieve a hematocrit of ~20%. Cardiopulmonary bypass was initiated through the femoral artery and right atrial cannulas. After 5 minutes normothermic bypass (37°C), animals were cooled to 20°C for more than 25 minutes using pH stat strategy, and DHCA was initiated. The heart was topically cooled with cold saline during DHCA. After 2 hours DHCA, CPB was reinitiated with warm perfusate. The animals were warmed to a rectal temperature of 35°C for more than 30 minutes and weaned from bypass. Animals were immediately sacrificed and tissues were harvested.

All animals in these studies received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (National Institutes of Health, Publication No. 86–23).

Collection of paired human atrial tissues
Pairs of human atrial samples were collected from patients undergoing cardiac surgery for repair or palliation of congenital heart defects, as previously described [4, 6]. The study protocol was approved by the Committee for Clinical Investigation at Children’s Hospital (Boston, MA). Ten pediatric patients (ages, 1 month to 32 months) were enrolled in the study after informed consent was obtained from their parents. The cardiac lesions of these patients included double outlet right ventricle [3], complete atrioventricular canal [4], truncus arteriosus [2], and heterotaxy/common atrium [1]. Median cross-clamp and total CPB pump times were 85 and 131 minutes, respectively (ranges, 67–103 minutes and 109–159 minutes). Circulatory arrest times were minimal (<= 11 minutes). Surgical technique and tissue collection has been previously described [4, 6]. Briefly, paired samples of human atrium were obtained just before CPB initiation and again at CPB termination. Specimens for RNA isolation were snap frozen in liquid nitrogen and stored at -80°C. Specimens for in-situ hybridization were soaked in 4% paraformaldehyde for 6 hours, in 30% sucrose overnight, then drained and stored at -80°C.

RNA preparation
Total RNA was extracted from human or lamb tissues by guanidinium-thiocyanate method with RNAzol B (Cinna/Biotecx, Friendswood, TX). Oligo-dT selected RNA was isolated by Oligotex-dT (Quiagen, Inc, Chatsworth, CA). The RNA was suspended in 0.5% SDS and quantitated spectrophotometrically.

Subtraction-hybridization and isolation of subtracted cDNA clones
Ischemic ovine ventricle for subtraction hybridization and cDNA library construction was obtained from neonatal lamb hearts subjected to CPB with 2 hours hypothermic arrest. Subtraction-hybridization was performed using the Subtractor kit (Invitrogen Corp, San Diego, CA) according to the manufacturer’s instructions. The induced pool of first-strand cDNA was prepared from 1 µg of ischemic-reperfused ovine oligo-dT-selected ventricular RNA by reverse transcription with oligo-dT primer (200 ng) at 42°C for 60 minutes. Template mRNA was removed by alkali treatment and induced first-strand cDNA was purified by phenol-chloroform extraction and ethanol precipitation. The control (noninduced) pool consisted of 10 µg oligo-dT-selected RNA from control (nonischemic) ovine ventricle. Control mRNA was photobiotinylated with photobiotin-acetate irradiated with a bright light. The photobiotinylated mRNA was then purified by multiple phenol-chloroform extractions. The large excess of photobiotinylated control mRNA driver was hybridized with induced first-strand cDNA for 48 hours at 68°C. Photobiotinylated mRNA-cDNA duplexes were removed by treatment with streptavidin followed by phenol-chloroform extraction, thus leaving the subtracted (induced - control) first-strand cDNA.

Subtraction probe was generated from subtracted cDNA by random-primed Klenow DNA polymerase reaction. The 32P-labeled probe was used to screen approximately 10,000 plaques of an ischemic sheep ventricle cDNA library [5], plated sparsely (500 to 1000 plaques per 150 mm plate) to allow isolation of single phage colonies. Fifty "subtracted" clones were obtained. Actin clones, presumed to be major contaminants of the subtraction screening, were screened and discarded by screening replica filters with human {gamma}-actin probe. Phage clones isolated after the subtraction screening were excised by ExAssist helper phage (Stratagene), and resultant pBluescript plasmids were purified for further analysis. Restriction mapping and DNA sequencing were used to assess the identity of subtracted cDNA clones, and Northern analysis was used to confirm induction of subtracted clones by CPB.

Northern analysis
Samples of total RNA (15 µg/lane) or oligo-dT selected RNA (1 µg/lane) were denatured, separated by electrophoresis, and transferred to Magnagraph membranes (MicronTechnology, Westborough, MA). Hybridization probes included cDNA templates isolated by subtraction-hybridization, human c-fos, murine c-jun and human {gamma}-actin labeled with 32P by random primed Klenow DNA polymerase reactions. Blots were hybridized overnight at 42°C, washed, and exposed. Hybridization of blots with {gamma}-actin probe served as an internal control for RNA loading. Signals were quantified using ImageQuant software after overnight exposures on PhosphorImager screens (Molecular Dynamics, Sunnyvale, CA).

In-situ hybridization
Hybridization was performed on cryopreserved sections of human and ovine myocardium using 35S-labeled riboprobes specific for human c-jun and c-fos and ovine c-jun as previously described [6]. The cDNA for human c-jun (IMAGE clone 41019; nt 933–2221) and c-fos (EST 74940; full-length 180 nt) for production of sense and antisense riboprobes were obtained from ATCC (Rockville, MD) and cloned into pBluescript. Ovine c-jun and TIS7 were cloned as phagemids from a {lambda}-ZAP-II ischemic-reperfused lamb lung library [5], and were used directly as templates for riboprobe synthesis. To evaluate expression patterns for human c-fos and c-jun, a blinded observer (EJN) assessed paired atrial sections from 3 human subjects for each gene, with sections from 2 of the subjects analyzed for both c-fos and c-jun. Ovine c-jun expression was examined in a blinded manner by the same observer in myocardial sections from 3 control lambs and 3 lambs subjected to CPB/DHCA.

Reverse transcriptase-polymerase chain reaction
The RNA from paired human atrial samples (n = 5 subjects) pre-CPB and post-CPB were subjected to Superscript reverse transcriptase (RT) (Stratagene, LaJolla, CA) and polymerase chain reaction (PCR) with primers for human iNOS and ß-actin iNOS primers were 5'ATTCAGGTACGCTGTGTTTGG 3' (sense) and 5'CATGGTGAACACGTTCTTGG 3' 351 bp predicted product - nt 2060–2411 in iNOS cDNA genbank accession number L09210). A water blank served as a negative control. The COS cells transfected with full-length iNOS cDNA served as positive controls.


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Using myocardial RNA isolated from control (nonischemic) and induced (CPB/DHCA) myocardium, 50 cDNA clones were isolated by subtraction library screening. Subtraction cloning results are summarized in Table 1. After restriction mapping and sequence analysis, a total of 9 subtracted clones were analyzed by Northern analysis using 32P labeled ECOR1 fragments of subtracted cDNA clones. Five subtraction clones were found to represent genes induced by CPB/DHCA. Among the induced genes, subtraction clone 13 was identified to be the ovine homolog of murine TIS7/rat PC4, an interferon-related immediate early gene first cloned in cultured rat astrocytes [7, 8]. Figure 1 shows a poly-A Northern blot of pre-CPB and post-CPB ovine myocardium demonstrating induction of subtraction clone 13 at termination of bypass. Homology search of clone 13 revealed homology to murine TIS7/rat PC4 (predicted ovine amino acid sequence from Blast search: KGDEQRAAAALASVLCIQLGPGIESEEVLKTLGPILKKIICDGTASIQARQTCATCFGVC). Attempted in situ hybridization of TIS7 transcripts in ovine tissue was unsuccessful, presumably due to the low prevalence of these transcripts (results not shown).


View this table:
[in this window]
[in a new window]
 
Table 1. Summary of 50 Clones Harvested by Subtraction Hybridization

 


View larger version (48K):
[in this window]
[in a new window]
 
Fig 1. Immediate early gene identified in subtraction screening induced at termination of bypass and circulatory arrest in ovine ventricle. Representative Northern analysis of oligo-dT-selected RNA from control neonatal lamb ventricle and ventricle collected immediately after bypass and circulatory arrest, probed with cDNA fragment of subtraction clone 13. Blast search with clone 13 sequence identified close homology with murine TIS7/rat PC4.

 
The subtraction results prompted us to examine expression of the related immediate early genes, c-fos and c-jun, in human and ovine myocardium subjected to CPB with ischemia-reperfusion. Figure 2 displays a representative total RNA Northern blot of ovine myocardium subjected to sternotomy only (pre-CPB/DHCA) or CPB with 2 hours DHCA (post-CPB/DHCA). The blots were probed with human c-fos, murine c-jun, and human {gamma}-actin. Marked myocardial induction of c-fos and c-jun expression immediately upon termination of CPB was evident in all (n = 3) lamb hearts subjected to CPB/DHCA.



View larger version (48K):
[in this window]
[in a new window]
 
Fig 2. Marked induction of c-fos and c-jun mRNA was observed in neonatal lamb ventricle at termination of bypass and circulatory arrest (n = 3 lambs). Representative total RNA Northern blot of control neonatal lamb ventricle (Pre) and ventricle collected immediately after bypass and 2 hours circulatory arrest (Post). Blots were probed with 32P labeled cDNA fragments of c-fos and c-jun, respectively. The internal control for each lane was human {gamma}-actin cDNA. (DHCA = deep hypothermic circulatory arrest.)

 
To investigate the expression patterns of c-jun and c-fos in reperfused myocardial tissue, in situ hybridization was performed on ovine ventricular (n = 3) and human atrial sections (n = 3 subjects for analysis of each gene) isolated at termination of CPB and examined by a blinded observer (EJN). Expression of both c-fosand c-jun was examined in adjacent atrial sections from two subjects. Although both c-jun and c-fos were induced by CPB-related ischemia, their patterns of myocardial expression differed markedly. In ischemic-reperfused ovine ventricle (Fig 3) and human atrial myocardium (Fig 4), expression of c-jun was patchy, with areas of intense localized expression (see arrows in Figs 3 and 4). By contrast, expression of c-fos was diffuse and homogenous throughout the myocardium (Fig 5). Expression of c-jun and c-fos mRNA was negligible in both ovine and human myocardium before CPB (Figs 2, 3, and 5). Attempts to develop an ovine c-fos riboprobe were unsuccessful.



View larger version (75K):
[in this window]
[in a new window]
 
Fig 3. Representative in-situ hybridization of lamb ventricular myocardium showing patchy, but intense focal induction of c-jun mRNA at termination of bypass and circulatory arrest (mag = 40 x objective). (A) Control (nonischemic) ventricular myocardium. (B) Ventricular myocardium at termination of bypass demonstrating mild diffuse induction and a focus of strong perivascular induction that may represent an inflammatory cell (arrow). (C) Sense riboprobe (negative control) on postbypass myocardium demonstrates minimal background staining.

 


View larger version (138K):
[in this window]
[in a new window]
 
Fig 4. Representative in-situ hybridization of human atrial myocardium demonstrating patchy, focal induction of c-jun mRNA at termination of bypass with associated myocardial ischemia (mag = 40x objective). (A) and (B) Two separate examples of "hot spots" (arrows) for c-jun mRNA in briefly reperfused human atrial myocardium at end-bypass. Transcripts for c-jun were not detected in prebypass atrial tissue (data not shown).

 


View larger version (102K):
[in this window]
[in a new window]
 
Fig 5. Representative in situ hybridization of human atrial myocardium demonstrating diffuse induction of c-fos mRNA immediately upon termination of bypass with associated myocardial ischemia. Sections are shown at low magnification (10 x objective) to demonstrate diffuse nature of c-fos expression. Dark-field (A, C, and E) and corresponding bright-field (B, D, and F) photomicrographs. (A), (B) Prebypass. (C), (D) Briefly reperfused atrial tissue at end-bypass demonstrates predominantly diffuse myocardial induction, with rare high-intensity foci. (E), (F) Sense riboprobe (negative control) shows minimal staining.

 
Figure 6 demonstrates results of iNOS RT-PCR analysis in paired human atrial tissue collected at the onset and termination of CPB with myocardial ischemia. The iNOS expression was undetectable in human atrial tissue at onset and termination of CPB (n = 5 patients). RT-PCR was utilized after RNAse protection and Northern analyses failed to show iNOS expression in human and ovine myocardium at termination of CPB (results not shown).



View larger version (40K):
[in this window]
[in a new window]
 
Fig 6. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis demonstrates absence of iNOS mRNA expression in briefly reperfused human atrium at termination of bypass (n = 5 subjects). (A) Representative gel demonstrating iNOS fragment amplified by RT-PCR; Lane 1 = water only (negative control); Lane 2 = prebypass atrial tissue; Lane 3 = Briefly reperfused atrial tissue at end-bypass; Lane 4 = monkey kidney COS cells transfected with human iNOS cDNA. (B) Control human {gamma}-actin amplified fragment, observed as expected in human atrial tissue only (lanes 2 and 3).

 

    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Inflammatory injury after CPB is a multifactorial phenomenon involving a multitude of inflammatory mediators [1]. Both cytokines and adhesion molecules are known to be upregulated after CPB [46], but initiating events of bypass-mediated inflammation are still largely unknown. To identify novel or previously unrecognized genes induced by CPB with myocardial ischemia, subtraction-hybridization was used to analyze differential gene expression in a lamb model of CPB. Among the CPB-induced genes identified by subtraction-hybridization was the immediate early gene TIS7/PC4 [7, 8], which prompted us to characterize expression of the related immediate early genes c-fos and c-jun in ischemic-reperfused human and ovine myocardium subjected to CPB. The role of TIS7/PC4 in CPB-mediated inflammatory injury is unknown, but other immediate early genes participate in signal transduction and activation of downstream genes (eg, c-jun and c-fos combine to form the transcription factor AP-1). Immediate early genes have been shown to participate in myocardial and vascular remodeling after injury [13]. Furthermore, since immediate early genes are rapidly induced in hypoxic cultured cardiomyocytes [10] and other ischemic tissues [14, 15], immediate early genes are likely to contribute to activation of other genes involved in bypass-mediated inflammation.

Our data demonstrate rapid activation of immediate early genes (c-jun, c-fos, TIS7) in briefly reperfused myocardial tissue at end-CPB, whereas iNOS transcripts were yet undetectable even by RT-PCR. In-situ hybridization demonstrated that tissue expression patterns of c-fos and c-jun were markedly different; myocardial c-fos expression was diffusely homogeneous, whereas c-jun expression was patchy with areas of intense focal localization. Although attempts to develop an ovine c-fos riboprobe were unsuccessful, the expression pattern differences are well demonstrated in ischemic-reperfused human atrial tissue. Because both c-jun and c-fos proteins are required for functional AP-1 transcriptional regulation, differences in their tissue expression patterns presumably modulate the activation of downstream genes. These data suggest that activation of genes associated with postbypass inflammation may be modulated by spatial and temporal factors in addition to transcriptional control (ie, activation of genes induced by AP-1 will be pinpointed in areas with high expression of both c-jun and c-fos).

One of the early response genes found to be induced by CPB, the ovine homolog of murine TIS7/rat PC4 [7, 8], was identified by subtraction cloning. Subtraction hybridization was used to isolate gene transcripts induced by CPB and myocardial ischemia. Interferon-related TIS7 (TPA inducible sequence 7) is induced rapidly in cultured neural cell lines by growth factors and phorbol esters [79]. Its proposed actions include tumor suppressor activity [9] and transcriptional regulation of myoblast differentiation [16]. Our observation that TIS7/PC4 is induced by CPB is the first report that it may play a role in ischemia-reperfusion injury. Enthusiasm for differential gene expression analyses has been fueled by the emergence of powerful new high-throughput techniques; subtraction hybridization can complement such analyses [17]. Current microarray technologies are biased toward known genes and those genes thought to be involved in a certain process, as determined by the genes applied to commercially available chips or filters. In contrast, subtraction methods allow detection of novel or unexpected genes. Genes identified by subtraction screening are good candidates for inclusion on subsequent arrays.

Although there is evidence that iNOS activity [2, 18] is altered by CPB, the pattern and time course of expression is not well characterized. Activation of iNOS requires cytokine-activation resulting in a "delayed" response [2, 11]. Our findings would suggest that myocardial iNOS is not yet upregulated at termination of CPB. Studies in rats subjected to endotoxemia and ischemia-reperfusion injury demonstrate delayed expression of iNOS mRNA, with only slight increases in iNOS expression detectable by 2 hours reperfusion and peak levels not detected until 6 to 8 hours after the inflammatory insult [11]. The finding that iNOS transcripts were undetectable by RT-PCR in human atrial tissue at termination of bypass (with minimal reperfusion) is thus consistent with previous work.

In summary, the data suggest that immediate early gene activation occurs promptly after CPB and likely participates in signal transduction leading to the myocardial inflammatory process. Differences in tissue expression patterns of these early-response genes, as observed for c-jun and c-fos, presumably modulate their effect upon downstream gene activation.


    Acknowledgments
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Supported by NIH grant SPO1 HL48675 (JEM, JWN) and K24HL04184 (EJN).


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Edmonds L.H., Jr Inflammatory and immunological response to cardiopulmonary bypass. In: Jonas R.A., Elliot M.J., eds. Cardiopulmonary bypass in neonates, infants and young children. Oxford: Butterworth-Heineman, 1994:225-241.
  2. Hill G.E., Whitten C.W., Landers D.F. The influence of cardiopulmonary bypass on cytokines and cell-cell communication. J Cardiothorac Vasc Anesth 1997;11:367-375.[Medline]
  3. Wernovsky G., Wypij D., Jonas R.A., et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226-2235.[Abstract/Free Full Text]
  4. Kilbridge P.M., Mayer J.E., Newburger J.W., et al. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:1183-1192.[Abstract/Free Full Text]
  5. Burns S.A., DeGuzman B.J., Newburger J.W., et al. P-selectin expression in myocardium of children undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;110(4 Pt 1):924-933.[Abstract/Free Full Text]
  6. Burns S.A., Newburger J.W., Xiao M., et al. Induction of interleukin-8 messenger RNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation 1995;92(Suppl 9):II315-II321.
  7. Tirone F., Shooter E.M. Early gene regulation by nerve growth factor in PC12 cells: induction of an interferon-related gene. Proc Natl Acad Sci 1989;86:2088-2092.[Abstract/Free Full Text]
  8. Varnum B.C., Reddy S.T., Koski R.A., Herschman H.R. Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3. J Cell Physiol 1994;158:205-213.[Medline]
  9. Latif F., Duh F.M., Bader S., et al. The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21. Hum Genet 1997;99:334-341.[Medline]
  10. Webster K.A., Discher D.J., Bishopric N.H. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J Biol Chem 1993;268:16852-16858.[Abstract/Free Full Text]
  11. Luss H., Watkins S.C., Freeswick P.D., et al. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol 1995;27:2015-2029.[Medline]
  12. Schermerhorn M.L., Tofukuji M., Khoury P.R., et al. Sialyl lewisx oligosaccharide preserves cardiopulmonary, and endothelial function after hypothermic circulatory arrest in lambs. J Thorac Cardiovasc Surg 2000;120:230-237.[Abstract/Free Full Text]
  13. Chien K.R., Zhu H., Knowlton K.U., et al. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol 1993;55:77-95.[Medline]
  14. Goto S., Matsumoto I., Kamada N., et al. The induction of immediate early genes in postischemic and transplanted livers in rats. Its relation to organ survival. Transplantation 1994;58:840-845.[Medline]
  15. Bokesch P.M., Halpin D.P., Ranger W.R., et al. Immediate-early gene expression in ovine brain after hypothermic circulatory arrest: effects of aptiganel. Ann Thorac Surg 1997;64:1082-1088.[Abstract/Free Full Text]
  16. Guardavaccaro D., Ciotti M.T., Schafer B.W., et al. Inhibition of differentiation in myoblasts deprived of the interferon- related protein PC4. Cell Growth Differ 1995;6:159-169.[Abstract]
  17. Sehl P.D., Tai J.T.N., Hillan K.J., et al. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 2000;101:1990-1999.[Abstract/Free Full Text]
  18. Delgado R., Rojas A., Glaria L.A., et al. Ca(2+)-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass. Thorax 1995;50:403-404.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
J. Seeburger, J. Hoffmann, H. P. Wendel, G. Ziemer, and H. Aebert
Gene Expression Changes in Leukocytes During Cardiopulmonary Bypass Are Dependent on Circuit Coating
Circulation, August 30, 2005; 112(9_suppl): I-224 - I-228.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. C. Stoica, D. K. Satchithananda, C. Atkinson, S. Charman, M. Goddard, and S. R. Large
Heat shock protein, inducible nitric oxide synthase and apoptotic markers in the acute phase of human cardiac transplantation
Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 932 - 939.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Ruel, C. Bianchi, T. A. Khan, S. Xu, J. R. Liddicoat, P. Voisine, E. Araujo, H. Lyon, I. S. Kohane, T. A. Libermann, et al.
Gene expression profile after cardiopulmonary bypass and cardioplegic arrest
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1521 - 1530.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Huang, S. B. Petkova, A. W. Cohen, B. Bouzahzah, J. Chan, J.-n. Zhou, S. M. Factor, L. M. Weiss, M. Krishnamachary, S. Mukherjee, et al.
Activation of Transcription Factors AP-1 and NF-{kappa}B in Murine Chagasic Myocarditis
Infect. Immun., May 1, 2003; 71(5): 2859 - 2867.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Takuya Miura
John E. Mayer, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, D. P.
Right arrow Articles by Neufeld, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, D. P.
Right arrow Articles by Neufeld, E. J.
Related Collections
Right arrow Extracorporeal circulation


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS